Chronic Illness Articles
Grifols, the world’s third largest manufacturer of plasma-based therapeutics and a leader in immunohematology and transfusion medicine diagnostics, has been patiently developing a novel approach to treatment of AD, based on plasma exchange and replacement with donor human albumin.
There is no effective treatment for this devastating disease, but research is paving the way for better diagnostic methods and new therapies to prevent, slow or stop it.
For resuscitation of patients with sepsis, the verdict is in: Hydroxyethyl starch products increase the risk of acute kidney injury and death.
Early referral for workup of patients with any of more than 150 occult primary immunodeficiency diseases can dramatically reduce hospitalizations, permanent disability and high costs of care.
While a cure remains elusive, strides in treatment options are increasingly controlling symptoms and giving patients a positive long-term prognosis.
With the rising rates of autoimmune disease, the quest is on to research and develop new medicines to treat patients who often present with multiple disorders.
From dietary supplements and acupuncture to yoga and meditation, many on-the-fringe interventions are becoming more accepted by patients and practitioners.